(VIANEWS) – Shares of Xenetic Biosciences (XBIO) slid by a staggering 17.69% to $4.36 at 10:26 EST on Friday, after four sequential sessions in a row of gains. NASDAQ Composite is falling 0.38% to $14,721.60, after two successive sessions in a row of gains. This seems, as yet, a somewhat bearish trend exchanging session today.
Xenetic Biosciences’s last close was $3.21, 45.13% below its 52-week high of $5.85.
Today’s last reported volume for Xenetic Biosciences is 10542786 which is 41.14% above its average volume of 7469830.
The company’s growth estimates for the ongoing quarter is a negative 6.7% and positive 85% for the next.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 786.7%, now sitting on 436.94k for the twelve trailing months.
Xenetic Biosciences’s last week, last month’s, and last quarter’s current volatility was 8.71%, 1.07%, and 4.79%, respectively.
Xenetic Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.71% (last week), 6.66% (last month), and 4.79% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be oversold (<=20).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $4.36 at 10:26 EST, way below its 52-week high of $5.85 and way higher than its 52-week low of $0.76.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s value is way higher than its 50-day moving average of $2.10 and way higher than its 200-day moving average of $2.29.
More news about Xenetic Biosciences (XBIO).